An esophagobronchial fistula, an abnormal passageway formed between the esophagus and bronchus, can cause severe respiratory symptoms. This fistula is a complication that can occur during chemoradiotherapy for esophageal and lung cancers; however, to our knowledge, no esophagobronchial fistulas during preoperative chemotherapy for lung cancer have been reported. The patient was a 55-year-old man whose chest computed tomography (CT) revealed a mass on the dorsal bronchus and right side of the esophagus. A transesophageal needle biopsy confirmed the diagnosis of lung adenocarcinoma, and preoperative chemotherapy, which included pembrolizumab, was administered. One week after the first course of chemotherapy, the patient developed a severe cough after drinking water. Chest CT revealed an esophagobronchial fistula, which prompted the discontinuation of the preoperative chemotherapy. Subsequent conservative treatment resulted in no improvement, and the patient was referred to our department. One month thereafter, a two-stage reconstruction of the esophagus was performed via the posterior sternal route. The resected specimen showed no residual tumor in the lungs, and the treatment was determined to result in a complete pathological response. The patient is currently undergoing maintenance therapy with pembrolizumab as a single agent. This is a rare case of esophagobronchial fistula identified during preoperative chemotherapy that included pembrolizumab for lung cancer. In addition to suturing the fistula, filling it with a distal hyoid valve was effective in treating the esophagobronchial fistula.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11148842PMC
http://dx.doi.org/10.7759/cureus.59666DOI Listing

Publication Analysis

Top Keywords

esophagobronchial fistula
20
preoperative chemotherapy
20
lung cancer
12
fistula
8
chemotherapy lung
8
chemotherapy included
8
included pembrolizumab
8
esophagobronchial
6
chemotherapy
6
preoperative
5

Similar Publications

An esophagobronchial fistula, an abnormal passageway formed between the esophagus and bronchus, can cause severe respiratory symptoms. This fistula is a complication that can occur during chemoradiotherapy for esophageal and lung cancers; however, to our knowledge, no esophagobronchial fistulas during preoperative chemotherapy for lung cancer have been reported. The patient was a 55-year-old man whose chest computed tomography (CT) revealed a mass on the dorsal bronchus and right side of the esophagus.

View Article and Find Full Text PDF

Management of neo-esophagus-airway fistula after esophagectomy for oesophageal cancer: systematic literature review and meta-analysis.

Interdiscip Cardiovasc Thorac Surg

July 2024

Department of Thoracic Surgery and Heart and Lung Transplantation, Hôpital Marie Lannelongue, Université Paris-Saclay, Le Plessis Robinson, France.

Objectives: Neo-oesophageal-airway fistula (NEAF) between gastric conduit and airway is a rare but life-threatening complication of oesophagectomy for oesophageal cancer. Optimal treatment remains unknown. A meta-analysis of good-quality case series may help determine whether nonoperative management (NOM) only, upfront surgery (S), or NOM followed by surgery is associated with better 1-year post-treatment mortality, resumption of oral diet and fistula recurrence.

View Article and Find Full Text PDF

Esophageal perforation due to soft coagulation heat injury after right lower lobectomy: A case report.

Int J Surg Case Rep

February 2024

Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, 7-15 Kita-ku, Sapporo, Hokkaido 060-8638, Japan. Electronic address:

Introduction: Soft coagulation is a hemostatic system of electrosurgical units that automatically regulates its output to avoid carbonization or incision. This system is widely used in invasive procedures, including thoracic surgery. Few reports exist on the harmful effects of these devices.

View Article and Find Full Text PDF
Article Synopsis
  • A rare de novo variant (p.Tyr40His) was found in a male patient with severe congenital anomalies, leading to a fatal respiratory condition shortly after birth.
  • The study showed that this specific variant weakly interacts with the protein PAK1, hindering its activation and potentially disrupting important signaling pathways that could explain the patient's clinical issues.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!